Skip to content
Disclosery

NVP ASSOCIATES, LLC

Follow

13F filer, CIK 1545692, MENLO PARK, CA

NVP ASSOCIATES, LLC reported $112,176,918 across 6 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001415889-25-012671

Period
2025-03-31
Reported value
$112M
Holdings
6
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GROVadded+281,575$380K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
UDMYexited-3,114,732-$25.6M
TALKreduced-4,900,000-$12.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001415889-25-012671, largest first. % of portfolio is the value over $112,176,918, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DAVEDAVE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 582,675 shares; 2024Q4: 582,675 shares; 2025Q1: 582,675 shares 582,675$48.2M42.94%0Timeline
TALKTALKSPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,702,972 shares; 2024Q4: 14,702,972 shares; 2025Q1: 9,802,972 shares 9,802,972$25.1M22.37%-4,900,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,136,335 shares; 2024Q4: 2,136,335 shares; 2025Q1: 2,136,335 shares 2,136,335$15.8M14.05%0Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,838,482 shares; 2024Q4: 1,838,482 shares; 2025Q1: 1,838,482 shares 1,838,482$14.5M12.95%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,943,522 shares; 2024Q4: 2,943,522 shares; 2025Q1: 3,225,097 shares 3,225,097$4.35M3.88%+281,575Timeline
OPENOPENDOOR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,189,562 shares; 2024Q4: 4,189,562 shares; 2025Q1: 4,189,562 shares 4,189,562$4.27M3.81%0Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
UDMYUDEMY INC3,114,732$25.6Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001415889-25-012671 base2025-05-12acceptance time not in the bulk data set